Q3 2024

Update on the utility of trabecular bone score (TBS) in clinical practice for the management of osteoporosis: a systematic review by the Egyptian Academy of Bone and Muscle Health

Yasser El Miedany · Walaa Elwakil · Mohammed Hassan Abu-Zaid · Safaa Mahran
10.1186/s43166-024-00252-x 391 المشاهدات 6 الاقتباسات
6
الاقتباسات
391
المشاهدات
الملخص

AbstractTrabecular bone score (TBS) is a grayscale textural assessment resulting from a computed evaluation of pixel gray-level variations in previously obtained lumbar spine DXA images. It is an index of bone microarchitecture correlated with parameters of bone strength. Higher values of TBS indicate a better microarchitecture, whereas lower values indicate a degraded microarchitecture. TBS can be used alongside Fracture Risk Assessment tool “FRAX” and bone mineral density (BMD) to enhance the assessment of fracture risk and to inform treatment initiation and monitoring. A systematic review was carried out aiming to update the evidence on the clinical use of the TBS in the management of both primary and secondary osteoporosis. Results revealed that in both primary and secondary osteoporosis, TBS enhances the prediction of fracture risk, and when adjust with BMD and clinical risk factors, it is able to inform the decision-making process regarding initiating osteoporosis therapy and the choice of anti-osteoporosis medication. Evidence also implies that TBS provides valuable adjunctive information in monitoring osteoporosis therapy. In conclusion, this work provides an up-to-date evidence-based review and recommendations which informs the utility of trabecular bone score in standard clinical practice.

الاستشهاد بهذا المقال (APA)
Yasser, E. M., Walaa, E., Mohammed, H. A., Safaa, M. (2024). Update on the utility of trabecular bone score (TBS) in clinical practice for the management of osteoporosis: a systematic review by the Egyptian Academy of Bone and Muscle Health. Egyptian Rheumatology and Rehabilitation. https://doi.org/10.1186/s43166-024-00252-x
أبحاث ذات صلة
Sleep quality, anxiety, depression, and quality of life in rheumatoid arthritis patients and impact …
Maha S. I. Abdelrahman; Ahmad M. Shaddad; Waleed Gamal Elddin Khaleel; Esraa A. · 2024
14
استشهاد
393
Serum malondialdehyde as a marker of oxidative stress in rheumatoid arthritis
Ghada A. Nabih; Nehal EEl Sheshtawy; Dalia M. E. El Mikkawy; Marwa A. Kamel · 2024
13
استشهاد
398
Vitamin D management update: evidence-based guidelines for vitamin D optimization by the Egyptian Ac…
Yasser El Miedany; Mathias Toth; Maha Mohamed El Gaafary; Safaa A. Mahran; Walee · 2025
10
استشهاد
394
TNF-α in the serum and synovial fluid of patients with rheumatoid arthritis: correlation with sonogr…
Aya El Hassany; Samar Tharwat; Mostafa Mansour; Asmaa Farouk Enein · 2024
8
استشهاد
391
Screening to prevent osteoporotic fractures in Egypt: a position statement of the Egyptian Academy o…
Yasser El Miedany; Maha El Gaafary; Naglaa Gadallah; Safaa Mahran; Mohamed Hassa · 2024
7
استشهاد
393
الوصول
عرض النص الكامل عبر DOI
نُشر في
الرقم الدولي ISSN 2090-3235
الربعية Q3
درجة المؤشر القياس العربي 76
التخصص Medicine & Health Sciences
الناشر Springer (Biomed Central Ltd.)
الدولة 🇪🇬 Egypt
عرض ملف المجلة →
المؤلفون
تفاصيل النشر
السنة 2024
اللغة English
أُضيف في 14 Aug 2026